PTEN and neoplasm: In addition to the genetic loss, PTEN can also be modulated at the posttranscriptional level via micro-RNAs [33] as well as long noncoding RNAs [34] providing possible targets for its replenishment within the tumor cells in addition to the implementation of PI3K inhibitors that might have undesired off-side effect(s).